Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H16N2O |
| Molecular Weight | 276.3324 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(NC3=C2C(C)=C4C=NC=CC4=C3C)C=C1
InChI
InChIKey=BKRMCDAOAQWNTG-UHFFFAOYSA-N
InChI=1S/C18H16N2O/c1-10-15-9-19-7-6-13(15)11(2)18-17(10)14-8-12(21-3)4-5-16(14)20-18/h4-9,20H,1-3H3
| Molecular Formula | C18H16N2O |
| Molecular Weight | 276.3324 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
9-methoxyellipticine is an indole alkaloid from the roots of Ochrosia acuminata. Antitumor properties of 9-methoxyellipticine were demonstrated. 9-Methoxyellipticine possesses a relatively broad spectrum of antitumor activity, 10
of 17 mouse neoplasms tested having responded. Both intraperitoneal and oral activity have been noted. Significant activity was seen against both the ascites and solid forms of the Walker rat carcinosarcoma 256. 9-methoxyellipticine binds DNA through a single step mechanism, can be considered as a pure intercalator.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1936 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16190746 |
0.3 µM [IC50] | ||
Target ID: CHEMBL2311221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1868167 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| tert-Butyl 6-bromo-1,4-dimethyl-9H-carbazole-9-carboxyl-ate. | 2010-07-10 |
|
| Alkaloids from the Australian rainforest tree Ochrosia moorei. | 2008-06 |
|
| Preparation of polyfunctional aryl azides from aryl triazenes. A new synthesis of ellipticine, 9-methoxyellipticine, isoellipticine, and 7-carbethoxyisoellipticine. | 2007-09-14 |
|
| New indole alkaloids from the roots of Ochrosia acuminata. | 2004-10 |
|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991-01-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5245921
Mice: 9-methoxyellipticine was demonstrated to be active in certain cases by both the intraperitoneal and oral routes. The corresponding dose ranges were from 12-24 mg/kg and 24-36 mg/kg, respectively.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15078993
MDA-MB-231 cells were treated with 5 uM 9-methoxyellipticine, which showed intermediate activity in the induction of apoptosis.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:19:53 GMT 2025
by
admin
on
Mon Mar 31 19:19:53 GMT 2025
|
| Record UNII |
U0924292N9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
72512
Created by
admin on Mon Mar 31 19:19:53 GMT 2025 , Edited by admin on Mon Mar 31 19:19:53 GMT 2025
|
PRIMARY | |||
|
69187
Created by
admin on Mon Mar 31 19:19:53 GMT 2025 , Edited by admin on Mon Mar 31 19:19:53 GMT 2025
|
PRIMARY | |||
|
U0924292N9
Created by
admin on Mon Mar 31 19:19:53 GMT 2025 , Edited by admin on Mon Mar 31 19:19:53 GMT 2025
|
PRIMARY | |||
|
10371-86-5
Created by
admin on Mon Mar 31 19:19:53 GMT 2025 , Edited by admin on Mon Mar 31 19:19:53 GMT 2025
|
PRIMARY | |||
|
233-812-0
Created by
admin on Mon Mar 31 19:19:53 GMT 2025 , Edited by admin on Mon Mar 31 19:19:53 GMT 2025
|
PRIMARY | |||
|
DTXSID50146028
Created by
admin on Mon Mar 31 19:19:53 GMT 2025 , Edited by admin on Mon Mar 31 19:19:53 GMT 2025
|
PRIMARY |